10 research outputs found
Genotype versus phenotype in families with androgen insensitivity syndrome
Androgen insensitivity syndrome encompasses a wide range of phenotypes,
which are caused by numerous different mutations in the AR gene. Detailed
information on the genotype/phenotype relationship in androgen
insensitivity syndrome is important for sex assignment, treatment of
androgen insensitivity syndrome patients, genetic counseling of their
families, and insight into the functional domains of the AR. The commonly
accepted concept of dependence on fetal androgens of the development of
Wolffian ducts was studied in complete androgen insensitivity syndrome
(CAIS) patients. In a nationwide survey in The Netherlands, all cases (n =
49) with the presumptive diagnosis androgen insensitivity syndrome known
to pediatric endocrinologists and clinical geneticists were studied. After
studying the clinical phenotype, mutation analysis and functional analysis
of mutant receptors were performed using genital skin fibroblasts and in
vitro expression studies. Here we report the findings in families with
multiple affected cases. Fifty-nine percent of androgen insensitivity
syndrome patients had other affected relatives. A total of 17 families
were studied, seven families with CAIS (18 patients), nine families with
partial androgen insensitivity (24 patients), and one family with female
prepubertal phenotypes (two patients). No phenotypic variation was
observed in families with CAIS. However, phenotypic variation was observed
in one-third of families with partial androgen insensitivity resulting in
different sex of rearing and differences in requirement of reconstructive
surgery. Intrafamilial phenotypic variation was observed for mutations
R846H, M771I, and deletion of amino acid N682. Four newly identified
mutations were found. Follow-up in families with different AR gene
mutations provided information on residual androgen action in vivo and the
development of the prepubertal and adult phenotype. Patients with a
functional complete defective AR had some pubic hair, Tanner stage P2, and
vestigial Wolffian duct derivatives despite absence of AR expression.
Vaginal length was functional in most but not all CAIS patients. The
minimal incidence of androgen insensitivity syndrome in The Netherlands,
based on patients with molecular proof of the diagnosis is 1:99,000.
Phenotypic variation was absent in families with CAIS, but distinct
phenotypic variation was observed relatively frequent in families with
partial androgen insensitivity. Molecular observations suggest that
phenotypic variation had different etiologies among these families. Sex
assignment of patients with partial androgen insensitivity cannot be based
on a specific identified AR gene mutation because distinct phenotypic
variation in partial androgen insensitivity families is relatively
frequent. In genetic counseling of partial androgen insensitivity
families, this frequent occurrence of variable expression resulting in
differences in sex of rearing and/or requirement of reconstructive surgery
is important information. During puberty or normal dose androgen therapy,
no or only minimal virilization may occur even in patients with
significant (but still deficient) prenatal virilization. Wolffian duct
remnants remain detectable but differentiation does not occur in the
absence of a functional AR. In many CAIS patients, surgical elongation of
the vagina is not indicated
De pasgeborene met een gestoorde geslachtelijke ontwikkeling
Contains fulltext :
69524.pdf (publisher's version ) (Closed access
A regression method including chronological and bone age for predicting final height in Turner syndrome with a comparison of existing methods
Item does not contain fulltex
The monotremes and the palimpsest theory. Bulletin of the AMNH ; v. 88, article 1
52 p., 2 p. of plates : ill. ; 27 cm.Includes bibliographical references: p. 46-52
Sexual Self-Concept in Women with Disorders/Differences of Sex Development
Many women born with disorders or differences of sex development (DSD) report sexual problems, in particular women who have undergone extensive genital reconstruction. Examining cognitions and emotions that hinder or promote sexuality may facilitate understanding these sexual problems and may contribute to the development of specific interventions. In this study, sexual self-concept, body image, and sexual functioning were investigated in relation to genital surgery. To conduct the study, the women's Sexual Self-Concept Scale was translated to Dutch. Evaluation of psychometric properties was conducted in a sample of healthy Belgian and Dutch women participating in an anonymous web-based survey (N = 589, Mdn age, 23 years). The resulting three-factor structure corresponded largely to that of the original version. Compared to control women, women born with a DSD who were included in the Dutch DSD study (N = 99, Mdn age, 26 years) described themselves as being less interested in sex and less sexually active. These women also harbored more negative emotions and cognitions regarding their sexuality and were less satisfied with their external genitalia. In women with a DSD, sexual self-concept was associated with compromised outcomes on sexual functioning and distress. Women who were in a steady relationship, and/or had been sexually active in the past 4 weeks had a more positive sexual self-concept, took a more active role in their sexual relationship, experienced more sexual desire and arousal and less sexual distress than women who were not involved in a partner relationship. Findings in this study indicate that cognitions and emotions related to sexual self-concept play a role in sexual functioning of women with a DSD. A cognitive behavioral counseling approach with focus on coping and exploration of their own sexual needs could prove useful in this group
A placebo-controlled double blind trial of growth-hormone treatment in prepubertal children after renal transplant.
Item does not contain fulltex
Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene.
BACKGROUND: Defective male sex differentiation in patients with hypoplasia of Leydig cells (LCH) is caused by deficient LH receptor signal transduction. To further investigate the variety of LH receptor gene mutations present in LCH patients and their influence on the phenotype, we examined 10 nonrelated patients with the clinical presentation of LCH. PATIENTS AND METHODS: Ten patients with a clinical phenotype of LCH were analysed for mutations in the complete coding region of the LH receptor gene. Exons 1-10 and two overlapping fragments of exon 11 of the LH receptor gene including all intron-exon boundaries were amplified by polymerase chain reaction and sequenced. To screen for frequencies of DNA changes, mutation analysis was performed on 45-59 healthy persons using denaturation high-performance liquid chromatography. RESULTS: Six new DNA alterations were identified. Three of them appear to be new polymorphisms. A G to C change at the 28th nucleotide of intron 1 on one allele and a heterozygous CGA to CAA transition at codon 124 (R124Q) were found. Both findings in these two patients are polymorphisms that occur with a frequency of 17% and 1.7%, respectively. A silent heterozygous CTA to TTA change at codon 204 was identified. In a patient with micropenis, the analysis revealed a homozygous missense mutation at codon 625 (I625K). As reported previously, this alteration significantly impaired signal transduction and explains the partial phenotype. Finally, in one compound heterozygous patient, two different mutations were discovered. At the polymorphic site in exon 1, a 27-bp insertion (CTG)2 AAG (CTG)5 CAG and a premature stop codon in the transmembrane segment 4 (W491*) were found. Both mutations disrupt signal transduction and explain the complete phenotype of this patient. In five patients, no DNA alterations could be identified. CONCLUSIONS: Three mutations (33 bp insertion in exon 1; W491* and I625K) were identified that explain the phenotype in two patients. In addition, most of the patients with the clinical phenotype of LCH did not have causative mutations, suggesting that changes in other regions of the LH receptor gene, such as the large introns or the promoter region, may be responsible for the majority of cases. Alternatively, the displayed phenotype may be the result of other genetic defects. Our work further underscores the importance of thorough clinical analysis of patients before molecular analysis of a particular gene is performed
A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty.
Item does not contain fulltex